High efficacy of generic and brand direct acting antivirals in treatment of chronic hepatitis C

Background: Direct acting antivirals (DAAs) are highly effective for treatment of hepatitis C (HCV) but brand products are priced beyond the means of most low and middle income countries (LMICs). Although a few DAAs are offered at reduced prices in access programs, they are still beyond affordabilit...

Full description

Bibliographic Details
Main Authors: Mai Abozeid, Ayman Alsebaey, Eman Abdelsameea, Warda Othman, Mostafa Elhelbawy, Amr Rgab, Marwa Elfayomy, Tamer Samir Abdel-Ghafar, Mervat Abdelkareem, Alyaa Sabry, Marwa Fekry, Nashwa Shebl, Eman Rewisha, Imam Waked
Format: Article
Language:English
Published: Elsevier 2018-10-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971218344862